Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126695031 | 12669503 | 1 | I | 20160805 | 20160812 | 20160819 | 20160819 | EXP | US-AMGEN-USASP2016106045 | AMGEN | 73.00 | YR | E | F | Y | 49.90000 | KG | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126695031 | 12669503 | 1 | PS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK | U | 103353 | UNKNOWN FORMULATION | ||||||||
| 126695031 | 12669503 | 2 | C | IBRANCE | PALBOCICLIB | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126695031 | 12669503 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126695031 | 12669503 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126695031 | 12669503 | Blood pressure decreased | |
| 126695031 | 12669503 | Dyspnoea | |
| 126695031 | 12669503 | Metastases to liver | |
| 126695031 | 12669503 | Red blood cell count decreased | |
| 126695031 | 12669503 | Unevaluable event | |
| 126695031 | 12669503 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126695031 | 12669503 | 2 | 201507 | 0 |